Concepedia

Sean Rudnick

SR

Statistics

Publications

14

Citations

566

H-Index

13

Active since

1983

Affiliations

Atrium Health Wake Forest Baptist(Current)

University of Washington

University of Colorado Boulder

Harvard University

Massachusetts General Hospital

Sean Rudnick is an author at Atrium Health Wake Forest Baptist specializing in medicine, metabolic porphyrias, and hematology.

Publications per year

1983–2023

14

Publications

14

Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy

Lawrence T. Goodnough, Thomas H. Price, Sean Rudnick et al. · Transfusion · 1992 · 150 citations

Medicine, Hematology, Perioperative Medicine +12

Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

David H. Henry, Beth Brooks, D. Case et al. · PubMed · 2006 · 72 citations

Medicine, Hematology, Pharmacology +16

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.

Marc S. Ernstoff, T Trautman, Carol A. Davis et al. · Journal of Clinical Oncology · 1987 · 54 citations

Pharmacy, Oncology, Pharmacokinetics +16

Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria

Amy K. Dickey, Hetanshi Naik, Sioḃán Keel et al. · Journal of the American Academy of Dermatology · 2022 · 43 citations · Full text

Medicine, Hematology, Pathobiology +9

Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.

Kempf Ra, Grunberg Sm, Daniëls et al. · PubMed · 1986 · 35 citations

Medicine, Immunology, Oncology +9

1–5 of 14